FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993947205> ?p ?o ?g. }

• W1993947205 endingPage "391" @default.
• W1993947205 startingPage "391" @default.
• W1993947205 abstract "Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons Haya Ascher-Svanum1, William S Montgomery2, David P McDonnell3, Kristina A Coleman4, Peter D Feldman11Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly Australia Pty Ltd, West Ryde, New South Wales, Australia; 3Eli Lilly and Company, Cork, Ireland; 4OptumInsight, Lilyfield, New South Wales, AustraliaBackground: Little is known about the comparative effectiveness of atypical antipsychotics in long-acting injection formulation. Due to the absence of head-to-head studies comparing olanzapine long-acting injection and risperidone long-acting injection, this study was intended to make exploratory, indirect, cross-study comparisons between the long-acting formulations of these two atypical antipsychotics in their effectiveness in treating patients with schizophrenia.Methods: Indirect, cross-study comparisons between olanzapine long-acting injection and risperidone long-acting injection used 12-month treatment-completion rates, because discontinuation of an antipsychotic for any cause is a recognized proxy measure of the medication&#39;s effectiveness in treating schizophrenia. Following a systematic review of the literature, two indirect comparisons were conducted using open-label, single-cohort studies in which subjects were stabilized on an antipsychotic medication before depot initiation. The first analysis compared olanzapine long-acting injection (one study) with pooled data from nine identified risperidone long-acting injection studies. The second analysis was a “sensitivity analysis,” using only the most similar studies, one for olanzapine long-acting injection and one for risperidone long-acting injection, which shared near-identical study designs and involved study cohorts with near-identical patient characteristics. Pearson Chi-square tests assessed group differences on treatment-completion rates.Results: Comparison of olanzapine long-acting injection data (931 patients) with the pooled data from the nine risperidone long-acting injection studies (3950 patients) provided almost identical 12-month treatment-completion rates (72.7% versus 72.4%; P = 0.87). When the two most similar studies were compared, the 12-month completion rate for olanzapine long-acting injection was significantly higher than for risperidone long-acting injection (81.3% versus 47.0%; P < 0.001). However, any conclusions drawn from this comparison may be limited by differences in the studies&#39; geographic catchment areas.Conclusion: Using treatment-completion rates as a proxy measure of medication effectiveness, olanzapine long-acting injection did not differ significantly from risperidone long-acting injection when including all eligible studies. However, the findings of this exploratory analysis should be interpreted with caution, considering the methodological limitations of these indirect, cross-study comparisons.Keywords: antipsychotic drugs, intramuscular injection, olanzapine, risperidone, schizophrenia" @default.
• W1993947205 created "2016-06-24" @default.
• W1993947205 creator A5011706362 @default.
• W1993947205 creator A5037912308 @default.
• W1993947205 creator A5047246416 @default.
• W1993947205 creator A5065363365 @default.
• W1993947205 creator A5086351925 @default.
• W1993947205 date "2012-05-01" @default.
• W1993947205 modified "2023-10-15" @default.
• W1993947205 title "Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons" @default.
• W1993947205 cites W122900622 @default.
• W1993947205 cites W1523943650 @default.
• W1993947205 cites W1769482660 @default.
• W1993947205 cites W1892201672 @default.
• W1993947205 cites W1965940175 @default.
• W1993947205 cites W1969486406 @default.
• W1993947205 cites W1985335881 @default.
• W1993947205 cites W1986620080 @default.
• W1993947205 cites W1989863594 @default.
• W1993947205 cites W1991993734 @default.
• W1993947205 cites W1992857340 @default.
• W1993947205 cites W1996291403 @default.
• W1993947205 cites W1998036667 @default.
• W1993947205 cites W2010599365 @default.
• W1993947205 cites W2014088019 @default.
• W1993947205 cites W2020615571 @default.
• W1993947205 cites W2022592863 @default.
• W1993947205 cites W2027885026 @default.
• W1993947205 cites W2029222500 @default.
• W1993947205 cites W2035752332 @default.
• W1993947205 cites W2037117217 @default.
• W1993947205 cites W2047069677 @default.
• W1993947205 cites W2055399347 @default.
• W1993947205 cites W2060407987 @default.
• W1993947205 cites W2073853327 @default.
• W1993947205 cites W2076607047 @default.
• W1993947205 cites W2083004141 @default.
• W1993947205 cites W2083601490 @default.
• W1993947205 cites W2088044851 @default.
• W1993947205 cites W2089145934 @default.
• W1993947205 cites W2098831733 @default.
• W1993947205 cites W2105267541 @default.
• W1993947205 cites W2107962758 @default.
• W1993947205 cites W2118032626 @default.
• W1993947205 cites W2129088827 @default.
• W1993947205 cites W2130848936 @default.
• W1993947205 cites W2132144498 @default.
• W1993947205 cites W2140273510 @default.
• W1993947205 cites W2140606211 @default.
• W1993947205 cites W2143267960 @default.
• W1993947205 cites W2148947471 @default.
• W1993947205 cites W2153153050 @default.
• W1993947205 cites W2154799984 @default.
• W1993947205 cites W2157180959 @default.
• W1993947205 cites W2157408003 @default.
• W1993947205 cites W2158669224 @default.
• W1993947205 cites W2158896618 @default.
• W1993947205 cites W2159039084 @default.
• W1993947205 cites W2159155203 @default.
• W1993947205 cites W2168661038 @default.
• W1993947205 cites W2174462147 @default.
• W1993947205 cites W3090293687 @default.
• W1993947205 doi "https://doi.org/10.2147/ijgm.s29052" @default.
• W1993947205 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3355848" @default.
• W1993947205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22615534" @default.
• W1993947205 hasPublicationYear "2012" @default.
• W1993947205 type Work @default.
• W1993947205 sameAs 1993947205 @default.
• W1993947205 citedByCount "10" @default.
• W1993947205 countsByYear W19939472052013 @default.
• W1993947205 countsByYear W19939472052014 @default.
• W1993947205 countsByYear W19939472052015 @default.
• W1993947205 countsByYear W19939472052016 @default.
• W1993947205 countsByYear W19939472052022 @default.
• W1993947205 crossrefType "journal-article" @default.
• W1993947205 hasAuthorship W1993947205A5011706362 @default.
• W1993947205 hasAuthorship W1993947205A5037912308 @default.
• W1993947205 hasAuthorship W1993947205A5047246416 @default.
• W1993947205 hasAuthorship W1993947205A5065363365 @default.
• W1993947205 hasAuthorship W1993947205A5086351925 @default.
• W1993947205 hasBestOaLocation W19939472051 @default.
• W1993947205 hasConcept C118552586 @default.
• W1993947205 hasConcept C15744967 @default.
• W1993947205 hasConcept C2776412080 @default.
• W1993947205 hasConcept C2776619155 @default.
• W1993947205 hasConcept C2776921671 @default.
• W1993947205 hasConcept C2778715236 @default.
• W1993947205 hasConcept C2780057945 @default.
• W1993947205 hasConcept C2780494398 @default.
• W1993947205 hasConcept C71924100 @default.
• W1993947205 hasConceptScore W1993947205C118552586 @default.
• W1993947205 hasConceptScore W1993947205C15744967 @default.
• W1993947205 hasConceptScore W1993947205C2776412080 @default.
• W1993947205 hasConceptScore W1993947205C2776619155 @default.
• W1993947205 hasConceptScore W1993947205C2776921671 @default.
• W1993947205 hasConceptScore W1993947205C2778715236 @default.
• W1993947205 hasConceptScore W1993947205C2780057945 @default.
• W1993947205 hasConceptScore W1993947205C2780494398 @default.

• next